Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas

Prognostic impact of activin subunit inhibin beta A in gastric and esophageal adenocarcinomas

Abstract Purpose Adenocarcinomas of the esophagus (AEG) and stomach (AS) are among the most common cancers worldwide. Novel markers for risk stratification and guiding treatment are strongly needed. Activin is a multi-functional cytokine with context specific pro- and anti-tumorigenic effects. We ai...

Full description

Bibliographic Details
Main Authors: J. J. Staudacher, Alexander Arnold, A. A. Kühl, M. Pötzsch, S. Daum, M. Winterfeld, E. Berg, M. Hummel, B. Rau, U. Stein, C. Treese
Format: Article
Language:English
Published: BMC 2022-09-01
Series:BMC Cancer
Subjects:
Gastric adenocarcinoma
Esophageal adenocarcinoma
Activin
INHBA
TGF-β superfamily
Online Access:https://doi.org/10.1186/s12885-022-10016-5

Internet

https://doi.org/10.1186/s12885-022-10016-5

Similar Items